Diabetes: The Impact of Clinical Pharmacy Services Integrated into Medical Homes on Diabetes-Related Clinical Outcomes

2010 ◽  
Vol 44 (12) ◽  
pp. 1877-1886 ◽  
Author(s):  
Kathleen A Johnson ◽  
Steven Chen ◽  
I-Ning Cheng ◽  
Mimi Lou ◽  
Paul Gregerson ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Clinical Pharmacy ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Medical Homes ◽  
The Impact

The impact of clinical pharmacy services in Nepal in the context of current health policy: a systematic review

2019 ◽  
Vol 28 (3) ◽  
pp. 245-255
Author(s):  
Reyaj Mikrani ◽  
Muhammad Naveed ◽  
Aman Mikrani ◽  
Sufia Yasmeen ◽  
MD. Akabar ◽  
...  
Keyword(s):  
Systematic Review ◽  
Health Policy ◽  
Clinical Pharmacy ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Current Health ◽  
The Impact

scholarly journals Hospital-Based Clinical Pharmacy Services to Improve Ambulatory Management of Chronic Obstructive Pulmonary Disease

2016 ◽  
Vol 33 (1) ◽  
pp. 8-14 ◽  
Author(s):  
Amber Lanae Smith ◽  
Valerie Palmer ◽  
Nada Farhat ◽  
James S. Kalus ◽  
Krishna Thavarajah ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Ambulatory Care ◽  
Pulmonary Disease ◽  
Clinical Pharmacy ◽  
Chronic Obstructive ◽  
Pharmacy Services ◽  
Obstructive Pulmonary Disease ◽  
Clinical Pharmacy Services ◽  
Significant Difference ◽  
The Impact

Background: No systematic evaluations of a comprehensive clinical pharmacy process measures currently exist to determine an optimal ambulatory care collaboration model for chronic obstructive pulmonary disease (COPD) patients. Objective: Describe the impact of a pharmacist-provided clinical COPD bundle on the management of COPD in a hospital-based ambulatory care clinic. Methods: This retrospective cohort analysis evaluated patients with COPD managed in an outpatient pulmonary clinic. The primary objective of this study was to assess the completion of 4 metrics known to improve the management of COPD: (1) medication therapy management, (2) quality measures including smoking cessation and vaccines, (3) patient adherence, and (4) patient education. The secondary objective was to evaluate the impact of the clinical COPD bundle on clinical and economic outcomes at 30 and 90 days post–initial visit. Results: A total of 138 patients were included in the study; 70 patients served as controls and 68 patients received the COPD bundle from the clinical pharmacist. No patients from the control group had all 4 metrics completed as documented, compared to 66 of the COPD bundle group ( P < .0001). Additionally, a statistically significant difference was found in all 4 metrics when evaluated individually. Clinical pharmacy services reduced the number of phone call consults at 90 days ( P = .04) but did not have a statistically significant impact on any additional pre-identified clinical outcomes. Conclusion: A pharmacist-driven clinical COPD bundle was associated with significant increases in the completion and documentation of 4 metrics known to improve the outpatient management of COPD.

Implementation of Ward-Based Clinical Pharmacy Services in Belgium—Description of the Impact on a Geriatric Unit

2006 ◽  
Vol 40 (4) ◽  
pp. 720-728 ◽  
Author(s):  
Anne Spinewine ◽  
Soraya Dhillon ◽  
Louise Mallet ◽  
Paul M Tulkens ◽  
Léon Wilmotte ◽  
...  
Keyword(s):  
Clinical Pharmacy ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Geriatric Unit ◽  
The Impact

scholarly journals Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists

2021 ◽  
Vol 11 (2) ◽  
pp. 59-63
Author(s):  
Nora Bairagdar ◽  
Ashley Reich ◽  
Jessica Bovio Franck
Keyword(s):  
Access To Care ◽  
Clinical Pharmacy ◽  
Primary Objective ◽  
Direct Patient Care ◽  
Quality Improvement Initiative ◽  
Pharmacy Services ◽  
Clinical Interventions ◽  
Clinical Pharmacy Services ◽  
Number Of Patients ◽  
The Impact

Abstract Introduction This quality improvement initiative aimed to implement a strategy to increase access to care with clinical pharmacy specialists (CPSs), optimize CPS direct patient care activities, and promote clinical pharmacy services. The primary objective was to assess the impact of patient marketing on expanding access to care and clinic utilization in a CPS clinic. Methods A marketing technique was applied by a mental health (MH) CPS to expand clinical pharmacy services. Direct-to-patient brochures advertising MH CPS comprehensive medication management services were placed at the check-in window of an interdisciplinary outpatient MH clinic. Brochure content included a description of an MH team, the role of MH CPSs, and benefits of being managed by MH CPSs. Patients could contact the MH CPS or speak to their primary provider for referral. The preintervention and postintervention evaluation periods were 4-month time frames. Clinic utilization for the MH CPS clinic was compared before and after dissemination of marketing brochures. Additional outcomes evaluated were number of encounters, number of patients seen, and number of clinical interventions completed by the MH CPS. Results There was a significant increase in clinic utilization postintervention. The total number of encounters, patients, and clinical interventions were numerically increased postintervention. Discussion The observed improvements in clinic utilization suggest the benefit of marketing in optimization of access to care in CPS clinics and justification of clinical pharmacy services.

Ambulatory Care Pharmacy Services: The Incomplete Agenda

1992 ◽  
Vol 26 (5) ◽  
pp. 701-708 ◽  
Author(s):  
Barry L. Carter ◽  
Dennis K. Helling
Keyword(s):  
Ambulatory Care ◽  
Patient Outcomes ◽  
Clinical Pharmacy ◽  
English Language ◽  
Data Extraction ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Standards Of Practice ◽  
Study Selection ◽  
The Impact

OBJECTIVE: To review studies that document the impact of clinical pharmacy services in ambulatory care settings and to propose standards of practice and resource allocation needs in ambulatory care. DATA SOURCES: English-language literature from 1970 through 1991 was reviewed and the representative literature is described. STUDY SELECTION: Studies were selected that examined the impact of clinical pharmacy services on patient outcomes and costs. Studies that evaluated pharmacist consultations by blind peer-review panels were also evaluated. DATA EXTRACTION: Trials were assessed based on their methodologies and ability to assess the value of clinical pharmacy services on patient outcomes. DATA SYNTHESIS: Numerous studies from the past 20 years are described illustrating the impact that ambulatory care pharmacy practitioners have made on patient care. These studies demonstrate that clinical pharmacists in ambulatory care not only serve as consultants on pharmacotherapy issues, but also can improve the quality of care for individual patients. CONCLUSIONS: Based on the studies cited and the needs of ambulatory patients, this article highlights the authors' views on what the standards of practice should be for ambulatory care practitioners and where resources should be allocated as ambulatory programs are expanded.

Redesigning the clinical pharmacy practice model at a psychiatric hospital

2015 ◽  
Vol 5 (1) ◽  
pp. 50-56
Author(s):  
Monica Zolezzi ◽  
Ingo Gottstein ◽  
Benjamin Nilsson
Keyword(s):  
Clinical Practice ◽  
Patient Outcomes ◽  
Clinical Pharmacy ◽  
Pharmacy Practice ◽  
Direct Patient Care ◽  
Pharmacy Services ◽  
Practice Model ◽  
Clinical Notes ◽  
Clinical Pharmacy Services ◽  
The Impact

Introduction: Integrated, patient-centered clinical pharmacy services have been shown to improve patient outcomes in a variety of settings, including mental health. In this article, we describe and report the impact of a restructured clinical practice model that incorporated direct patient care by pharmacists implemented at a psychiatric facility in Edmonton, Canada. The purpose of redesigning the clinical pharmacy program was to deliver proactive pharmacist care through integrated clinical pharmacy services and to better align pharmacists' activities with those that have been reported to have a positive impact on patient outcomes. Methods: Pharmacists' documentation notes in medical records for patients admitted and discharged from the hospital at four different time periods were reviewed. For each time period, the number, type, and documentation rate were measured and compared using a Student t test with correction for unequal variances. Significant change was defined as P &lt; .05. Documentation rates were also compared for short-stay versus long-stay patients. Results: A consistent and statistically significant increase was found in pharmacists' clinical notes per chart from 0.15 to 1.5 (P &lt; .001) after implementation of the redesigned clinical practice model. The proportion of clinical notes also increased from 22% in the preimplementation period to up to 68% in the current period. This indicates that pharmacists were spending proportionally more time on proactive versus reactive care. Documentation rates also increased regardless of the patients' length of stay. Discussion: The redesigned clinical practice model enabled a successful transition of the pharmacists' role, from being predominantly reactive to becoming more proactive and integrated.

Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic

2011 ◽  
Vol 17 (4) ◽  
pp. 387-394 ◽  
Author(s):  
Megan McKee ◽  
Bradi L Frei ◽  
Anita Garcia ◽  
David Fike ◽  
Scott A Soefje
Keyword(s):  
Clinical Pharmacy ◽  
Demographic Data ◽  
Counseling Services ◽  
Pharmacy Services ◽  
Cross Sectional Survey ◽  
Survey Tool ◽  
Clinical Pharmacy Services ◽  
Medication Therapy ◽  
The Impact

Background. Assessing the role of the pharmacist in an outpatient oncology clinic requires quantification of parameters that are important to the patient and the healthcare system. Patient evaluations not only serve as benchmarks for a process; but may also predict behavior such as utilization of care, continuity with the provider, and compliance. Purpose. To identify the role of the patient–pharmacist relationship and enhance patient satisfaction with care, a survey tool was developed and utilized. Methods. A 20-item, 2-page survey tool was developed and administered to oncology patients actively receiving treatment at the Cancer Therapy & Research Center (CTRC) in San Antonio, Texas. Following approval from the Investigational Review Board, survey distribution began on December 1, 2009 and continued through February 2010. Basic social and demographic data were collected. Satisfaction with pharmacy service was assessed with questions on a Likert ranking scale detailing time spent with pharmacists, knowledge of medication therapy, willingness to pay for clinical pharmacy services, etc. The primary outcome was the impact of the pharmacist–patient relationship assessed by examining the interaction between time spent with pharmacist, understanding of medications, and desire for future pharmacy counseling services. Results. A total of 77 surveys were administered and collected. Of the patients surveyed, 86% stated that it is important for patients to discuss their treatment with a pharmacist and 76% requested pharmacy follow-up at future visits. Conclusion. This cross-sectional survey reveals that patients are interested in visiting with a pharmacist regularly during chemotherapy treatment and patients may be willing to pay for pharmacy counseling services.

The impact of clinical pharmacy services on pneumococcal vaccine frequency and appropriateness in a family medicine clinic

2020 ◽  
Vol 60 (2) ◽  
pp. 362-367
Author(s):  
Autumn L. Stewart-Lynch ◽  
Brittany Albert ◽  
Carly Bryan ◽  
Molly Graveno ◽  
Rachel I. Roper ◽  
...  
Keyword(s):  
Family Medicine ◽  
Clinical Pharmacy ◽  
Pneumococcal Vaccine ◽  
Pharmacy Services ◽  
Clinical Pharmacy Services ◽  
Medicine Clinic ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document